AVAH AVEANNA HEALTHCARE HLDGS INC revenue, earnings and financials

For the quarter ended July 4, 2026, AVEANNA HEALTHCARE HLDGS INC reported revenue of $670M (up 13.7% from a year earlier), net income of $40.3M and diluted EPS of $0.18; over the last four quarters revenue was $2.60B and net income $50.0M; for the fiscal year ended January 2026 revenue was $2.43B, up 20.2% on the year before.

AVAH annual revenue and earnings

• Fiscal year ended Jan 2026: revenue $2.43B, gross profit $810M, operating income $256M, net income $225K (margin 0.0%), EPS $1.05
• Fiscal year ended Dec 2024: revenue $2.02B, gross profit $636M, operating income $140M, net income −$10.9K (margin 0.0%), EPS −$0.06
• Fiscal year ended Dec 2023: revenue $1.90B, gross profit $595M, operating income $8.07M, net income −$135K (margin 0.0%), EPS −$0.71
• Fiscal year ended Dec 2022: revenue $1.79B, gross profit $553M, operating income −$642M, net income −$662M (margin -37.0%), EPS −$3.57
• Fiscal year ended Jan 2022: revenue $1.68B, gross profit $542M, operating income −$36.1M, net income −$117M (margin -7.0%), EPS −$0.69

AVAH quarterly revenue and earnings

• Quarter ended Jul 4, 2026: revenue $670M (up 13.7% year over year), net income $40.3M, EPS $0.18
• Quarter ended Apr 4, 2026: revenue $648M (up 15.9% year over year), net income $41.7M, EPS $0.19
• Quarter ended Jan 3, 2026 (from the annual report): revenue $662M (up 27.4% year over year), net income −$46.1M, EPS $0.83
• Quarter ended Sep 27, 2025: revenue $622M (up 22.2% year over year), net income $14.1M, EPS $0.06
• Quarter ended Jun 28, 2025: revenue $590M (up 16.8% year over year), net income $27.0M, EPS $0.13
• Quarter ended Mar 29, 2025: revenue $559M (up 14.0% year over year), net income $5.19M, EPS $0.03
• Quarter ended Dec 28, 2024 (from the annual report): revenue $520M (up 8.6% year over year), net income $40.1M, EPS $0.15
• Quarter ended Sep 28, 2024: revenue $509M (up 6.5% year over year), net income −$42.8M, EPS −$0.22
• Quarter ended Jun 29, 2024: revenue $505M (up 7.0% year over year), net income $13.9M, EPS $0.07
• Quarter ended Mar 30, 2024: revenue $491M (up 5.2% year over year), net income −$11.2M, EPS −$0.06
• Quarter ended Dec 30, 2023 (from the annual report): revenue $479M (up 6.1% year over year), net income $109M, EPS −$0.13
• Quarter ended Sep 30, 2023: revenue $478M (up 7.9% year over year), net income −$102M, EPS −$0.54
• Quarter ended Jul 1, 2023: revenue $472M (up 6.5% year over year), net income $25.6M, EPS $0.13
• Quarter ended Apr 1, 2023: revenue $466M (up 3.5% year over year), net income −$32.0M, EPS −$0.17
• Quarter ended Dec 31, 2022 (from the annual report): revenue $451M (up 9.0% year over year), net income −$238M, EPS −$1.28
• Quarter ended Oct 1, 2022: revenue $443M (up 7.7% year over year), net income $24.3M, EPS $0.13
• Quarter ended Jul 2, 2022: revenue $443M (up 1.6% year over year), net income −$474M, EPS −$2.56
• Quarter ended Apr 2, 2022: revenue $451M (up 8.0% year over year), net income $25.3M, EPS $0.14
• Quarter ended Jan 1, 2022 (from the annual report): revenue $414M, net income −$126M, EPS −$0.75
• Quarter ended Oct 2, 2021: revenue $411M, net income $2.09M, EPS $0.01

AVAH cash flow, buybacks and dividends

• Fiscal year ended Jan 2026: operating cash flow $126M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow $32.6M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow $22.7M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$48.4M, share buybacks n/a
• Fiscal year ended Jan 2022: operating cash flow −$11.4M, share buybacks n/a

AVAH balance sheet

• Jul 4, 2026: cash $97.2M, total assets $2.11B, total liabilities $1.82B, shareholders' equity $287M, long-term debt $1.28B
• Apr 4, 2026: cash $189M, total assets $2.02B, total liabilities $1.78B, shareholders' equity $240M, long-term debt $1.28B
• Jan 3, 2026: cash $193M, total assets $2.01B, total liabilities $1.82B, shareholders' equity $194M, long-term debt $1.29B
• Sep 27, 2025: cash $146M, total assets $1.81B, total liabilities $1.80B, shareholders' equity $9.18M, long-term debt $1.29B
• Jun 28, 2025: cash $101M, total assets $1.77B, total liabilities $1.78B, shareholders' equity −$12.0M, long-term debt $1.27B
• Mar 29, 2025: cash $71.5M, total assets $1.66B, total liabilities $1.76B, shareholders' equity −$100M, long-term debt $1.27B
• Dec 28, 2024: cash $84.3M, total assets $1.66B, total liabilities $1.79B, shareholders' equity −$124M, long-term debt $1.27B
• Sep 28, 2024: cash $78.5M, total assets $1.64B, total liabilities $1.80B, shareholders' equity −$156M, long-term debt $1.28B

What is AVAH's revenue?

AVEANNA HEALTHCARE HLDGS INC reported $2.60B of revenue over its last four quarters, through July 4, 2026.

Is AVAH profitable?

Yes. AVEANNA HEALTHCARE HLDGS INC earned $50.0M over the last four quarters.

What is AVAH's EPS?

Diluted earnings per share over the last four quarters were $1.26; $0.18 in the latest quarter.

AVAH ownership and insider trades · All stocks